94 Life Science companies

Fostering the Baltic deep tech and life science ecosystem.

Takeda Ventures focuses on high-caliber therapeutic and platform based opportunities around the world.

Adjuvant is a new type of investment firm. We finance the most promising life science technologies for high-burden public health challenges.

Nurturing great biomed companies with Asia focus.

Building blockbuster biotech companies leveraging science from Japan.

Fåhraeus Startup and Growth Fund is a Venture Capital fund that invests early in life science and tech companies.

4BIO Capital is an international venture capital firm focused solely on the advanced therapies sector.

We're creating a future in which both humans and the planet thrive. We combine available scientific knowledge and founder-type scientists into high-impact ventu…

At Third Rock, we push the boundaries of science and technology to make a difference in the lives of patients and their families.

RA Capital funds and builds healthcare and life science companies.

Investing in disruptive, early-stage biopharma companies across Europe.

We partner with outstanding entrepreneurs who harness groundbreaking science & technology to transform healthcare.

INITIATE co-creates companies. We focus on bold ideas at the intersection of healthcare, life sciences and technology.

We're Sagana, a new kind of firm on a mission to align outstanding financial returns with social and environmental impact.

Investing in the core technologies of the future - for real innovations in fast-growing markets.

Martlet Capital is an early-stage investor, providing patient capital to deep technology and life science startups.

Bayer is a global life science company with core competencies in healthcare and agriculture, committed to "Health for all, Hunger for none" through scientific i…

Global Health Investment Corporation (GHIC) is a nonprofit organization catalyzing the development of technologies to improve human health worldwide.

IndieBio is the birthplace of the great companies of tomorrow.

Investing in pre-seed and seed stage biotech start-ups within a niche focus in bio-remediation, bioengineering, cell & gene therapy, and longevity.